Hold-rated reports

904 tickers rated Hold
NewestHighest Score Ranks all reports in this rating group by score, highest first.
Air Products and Chemicals, Inc.
APD·Materials
B ★★★Hold
Current$304.84
Target$338.17
Return+10.9%
Nov 8, 2026

Air Products combines durable industrial-gas contracts, improving earnings and electronics demand with potential cash-flow recovery, but elevated leverage and residual hydrogen project risks limit its margin of safety.

Score
70
Ralliant Corporation
RAL·Technology
B ★★★Hold
Current$67.68
Target$76.65
Return+13.3%
Nov 7, 2026

Ralliant combines differentiated precision technologies, strong organic growth, and improving margins, but cyclical electronics demand, debt, and demanding cash-flow valuation constrain near-term upside.

Score
70
Arcutis Biotherapeutics, Inc.
ARQT·Healthcare
B ★★★Hold
Current$25.55
Target$30.27
Return+18.5%
Nov 7, 2026

Arcutis can compound value through ZORYVE's expanding dermatology franchise and improving cash generation, but slowing prescription growth, rising commercial expenses, and single-molecule dependence limit the margin of safety.

Score
70
Avnet, Inc.
AVT·Technology
B ★★★Hold
Current$79.28
Target$90.00
Return+13.5%
Nov 7, 2026

Avnet combines strong electronics-distribution operating leverage with an inexpensive earnings valuation, but substantial inventory funding needs and negative free cash flow threaten the sustainability of its recovery.

Score
70
Clover Health Investments, Corp.
CLOV·Healthcare
B ★★★Hold
Current$4.82
Target$6.13
Return+27.2%
Nov 7, 2026

Clover Health can compound value through rapid Medicare Advantage membership growth and technology-driven medical-cost improvement, but regulatory dependence and thin insurance margins challenge the durability of its earnings expansion.

Score
70
ArcBest Corporation
ARCB·Industrials
B ★★★Hold
Current$127.91
Target$153.10
Return+19.7%
Nov 7, 2026

ArcBest offers leveraged exposure to a freight-cycle recovery through its established LTL network and improving logistics margins, but below-cost-of-capital returns and restructuring execution risk limit near-term conviction.

Score
70
Avista Corporation
AVA·Utilities
B ★★★Hold
Current$40.23
Target$41.25
Return+2.5%
Nov 7, 2026

Avista offers durable regulated utility cash generation and an attractive dividend yield at discounted relative valuations, but persistent capital spending, dilution, and regulatory recovery delays limit per-share growth.

Score
70
Palomar Holdings, Inc.
PLMR·Financials
B ★★★Hold
Current$155.71
Target$169.50
Return+8.9%
Nov 7, 2026

Palomar combines profitable specialty insurance growth, strong ROE, and expanding product diversification, but its premium book-value valuation and exposure to catastrophe and reserve losses limit the margin of safety.

Score
70
Power Integrations, Inc.
POWI·Technology
B ★★★Hold
Current$40.26
Target$50.96
Return+26.6%
Nov 7, 2026

Power Integrations offers differentiated high-voltage semiconductor technology, strong cash generation, and industrial electrification upside, but cyclical demand, insider selling, and demanding growth assumptions constrain near-term conviction.

Score
70
Performance Food Group Company
PFGC·Consumer Staples
B ★★★Hold
Current$107.50
Target$118.23
Return+10.0%
Nov 7, 2026

Performance Food Group can compound earnings through independent restaurant market-share gains and distribution efficiency, but high leverage, modest ROIC, and narrow margins limit its valuation margin of safety.

Score
70
Ormat Technologies, Inc.
ORA·Utilities
B ★★★Hold
Current$91.90
Target$105.00
Return+14.3%
Nov 7, 2026

Ormat offers differentiated geothermal technology and long-term renewable power growth, but high capital intensity, substantial leverage, and weak free cash flow constrain near-term shareholder value creation.

Score
70
Acushnet Holdings Corp.
GOLF·Consumer Discretionary
B ★★★Hold
Current$80.74
Target$90.30
Return+11.8%
Nov 7, 2026

Acushnet's premium Titleist and FootJoy franchises generate durable returns and shareholder cash flow, but mature golf demand, tariff-related earnings normalization, and valuation sensitivity constrain near-term upside.

Score
70